Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016 (2016), Article ID 7141430, 19 pages
http://dx.doi.org/10.1155/2016/7141430
Research Article

Anti-Inflammatory Effects of Hyperbaric Oxygenation during DSS-Induced Colitis in BALB/c Mice Include Changes in Gene Expression of HIF-1α, Proinflammatory Cytokines, and Antioxidative Enzymes

1Department of Physiology and Immunology, Faculty of Medicine, University of Osijek, 31 000 Osijek, Croatia
2Department of Biology, University of Osijek, 31 000 Osijek, Croatia
3Department of Immunology and Biotechnology, Faculty of Medicine, University of Pécs, 7624 Pécs, Hungary
4Lymphoid Organogenesis Research Group, Szentágothai Research Center, University of Pécs, 7624 Pécs, Hungary
5Department of Histology and Embryology, Faculty of Medicine, University of Osijek, 31 000 Osijek, Croatia

Received 25 March 2016; Revised 8 July 2016; Accepted 12 July 2016

Academic Editor: Fábio Santos Lira

Copyright © 2016 Sanja Novak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Goyette, G. Boucher, D. Mallon et al., “High-density mapping of the MHC identifies a shared role for HLA-DRB101:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis,” Nature Genetics, vol. 47, no. 2, pp. 172–179, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Satsangi, M. S. Silverberg, S. Vermeire, and J.-F. Colombel, “The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications,” Gut, vol. 55, no. 6, pp. 749–753, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. R. A. Risquesa, P. S. Rabinovitch, and T. A. Brentnall, “Cancer surveillance in inflammatory bowel disease: new molecular approaches,” Current Opinion in Gastroenterology, vol. 22, no. 4, pp. 382–390, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Nathan and A. Cunningham-Bussel, “Beyond oxidative stress: an immunologist's guide to reactive oxygen species,” Nature Reviews Immunology, vol. 13, no. 5, pp. 349–361, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. H. J. Lee, E. S. Jung, J. H. Lee et al., “Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with mild-to-moderate ulcerative colitis,” Hepato-Gastroenterology, vol. 59, no. 117, pp. 1415–1420, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. W. J. Sandborn, B. G. Feagan, and G. R. Lichtenstein, “Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission,” Alimentary Pharmacology & Therapeutics, vol. 26, no. 7, pp. 987–1003, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. L. R. Sutherland, G. R. May, and E. A. Shaffer, “Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis,” Annals of Internal Medicine, vol. 118, no. 7, pp. 540–549, 1993. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Eskes, H. Vermeulen, C. Lucas, and D. T. Ubbink, “Hyperbaric oxygen therapy for treating acute surgical and traumatic wounds,” The Cochrane Database of Systematic Reviews, no. 12, Article ID CD008059, 2013. View at Google Scholar · View at Scopus
  9. V. G. Sunkari, F. Lind, I. R. Botusan et al., “Hyperbaric oxygen therapy activates hypoxia-inducible factor 1 (HIF-1), which contributes to improved wound healing in diabetic mice,” Wound Repair and Regeneration, vol. 23, no. 1, pp. 98–103, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Tuk, M. Tong, E. M. G. Fijneman, and J. W. Van Neck, “Hyperbaric oxygen therapy to treat diabetes impaired wound healing in rats,” PLoS ONE, vol. 9, no. 10, Article ID e108533, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Ueno, T. Omi, E. Uchida, H. Yokota, and S. Kawana, “Evaluation of hyperbaric oxygen therapy for chronic wounds,” Journal of Nippon Medical School, vol. 81, no. 1, pp. 4–11, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Drenjancevic, A. Kibel, D. Kibel, V. Seric, and A. Cosic, “Blood pressure, acid-base and blood gas status and indicators of oxidative stress in healthy male rats exposed to acute hyperbaric oxygenation,” Undersea and Hyperbaric Medicine, vol. 40, no. 4, pp. 319–328, 2013. View at Google Scholar · View at Scopus
  13. E. M. Camporesi and G. Bosco, “Mechanisms of action of hyperbaric oxygen therapy,” Undersea and Hyperbaric Medicine, vol. 41, no. 3, pp. 247–252, 2014. View at Google Scholar · View at Scopus
  14. S. R. Thom, “Oxidative stress is fundamental to hyperbaric oxygen therapy,” Journal of Applied Physiology, vol. 106, no. 3, pp. 988–995, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. E. Ziello, I. S. Jovin, and Y. Huang, “Hypoxia-Inducible Factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia,” The Yale Journal of Biology and Medicine, vol. 80, no. 2, pp. 51–60, 2007. View at Google Scholar · View at Scopus
  16. E. T. Clambey, E. N. McNamee, J. A. Westrich et al., “Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 41, pp. E2784–E2793, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Yao, C. Wei, J.-Y. Wang, R. Zhang, Y.-X. Li, and L.-S. Wang, “Effect of resveratrol on Treg/Th17 signaling and ulcerative colitis treatment in mice,” World Journal of Gastroenterology, vol. 21, no. 21, pp. 6572–6581, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. K. M. Comerford, T. J. Wallace, J. Karhausen, N. A. Louis, M. C. Montalto, and S. P. Colgan, “Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene,” Cancer Research, vol. 62, no. 12, pp. 3387–3394, 2002. View at Google Scholar · View at Scopus
  19. G. T. Furuta, J. R. Turner, C. T. Taylor et al., “Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia,” The Journal of Experimental Medicine, vol. 193, no. 9, pp. 1027–1034, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. N. A. Louis, K. E. Hamilton, G. Canny, L. L. Shekels, S. B. Ho, and S. P. Colgan, “Selective induction of mucin-3 by hypoxia in intestinal epithelia,” Journal of Cellular Biochemistry, vol. 99, no. 6, pp. 1616–1627, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. N. S. Chandel, D. S. McClintock, C. E. Feliciano et al., “Reactive oxygen species generated at mitochondrial Complex III stabilize hypoxia-inducible factor-1α during hypoxia: a mechanism of O2 sensing,” The Journal of Biological Chemistry, vol. 275, no. 33, pp. 25130–25138, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Lih-Brody, S. R. Powell, K. P. Collier et al., “Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease,” Digestive Diseases and Sciences, vol. 41, no. 10, pp. 2078–2086, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Ramonaite, J. Skieceviciene, G. Kiudelis et al., “Influence of NADPH oxidase on inflammatory response in primary intestinal epithelial cells in patients with ulcerative colitis,” BMC Gastroenterology, vol. 13, article 159, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Gulec, M. Yasar, S. Yildiz et al., “Effect of hyperbaric oxygen on experimental acute distal colitis,” Physiological Research, vol. 53, no. 5, pp. 493–499, 2004. View at Google Scholar · View at Scopus
  25. E. Koçak, S. Köklü, E. Akbal et al., “NaOH-induced Crohn's colitis in rats: a novel experimental model,” Digestive Diseases and Sciences, vol. 56, no. 10, pp. 2833–2837, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya, “A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice,” Gastroenterology, vol. 98, no. 3, pp. 694–702, 1990. View at Google Scholar · View at Scopus
  27. D. A. Rossignol, “Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis,” Medical Gas Research, vol. 2, no. 1, article 6, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Bessissow, B. Lemmens, M. Ferrante et al., “Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing,” The American Journal of Gastroenterology, vol. 107, no. 11, pp. 1684–1692, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Viennois, F. Chen, H. Laroui, M. T. Baker, and D. Merlin, “Dextran sodium sulfate inhibits the activities of both polymerase and reverse transcriptase: lithium chloride purification, a rapid and efficient technique to purify RNA,” BMC Research Notes, vol. 6, no. 1, article 360, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. J. B. Jeong, Y. K. Shin, and S.-H. Lee, “Anti-inflammatory activity of patchouli alcohol in RAW264.7 and HT-29 cells,” Food and Chemical Toxicology, vol. 55, pp. 229–233, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Aebi, “Catalase in vitro,” Methods in Enzymology, vol. 105, pp. 121–126, 1984. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Wendel, “Glutathione peroxidase,” in Enzymatic Basis of Detoxication, W. B. Jakoby, Ed., chapter 16, pp. 333–353, Academic Press, New York, NY, USA, 1980. View at Publisher · View at Google Scholar
  33. L. Flohe and F. Otting, “Superoxide dismutase assays,” Methods in Enzymology, vol. 105, pp. 93–104, 1984. View at Publisher · View at Google Scholar · View at Scopus
  34. P. S. Dulai, M. W. Gleeson, D. Taylor, S. D. Holubar, J. C. Buckey, and C. A. Siegel, “Systematic review: the safety and efficacy of hyperbaric oxygen therapy for inflammatory bowel disease,” Alimentary Pharmacology & Therapeutics, vol. 39, no. 11, pp. 1266–1275, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. M.-F. Chen, H.-M. Chen, S. W. N. Ueng, and M.-H. Shyr, “Hyperbaric oxygen pretreatment attenuates hepatic reperfusion injury,” Liver, vol. 18, no. 2, pp. 110–116, 1998. View at Google Scholar · View at Scopus
  36. C. Luongo, F. Imperatore, S. Cuzzocrea et al., “Effects of hyperbaric oxygen exposure on a zymosan-induced shock model,” Critical Care Medicine, vol. 26, no. 12, pp. 1972–1976, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Sakashita, E. Hiyama, Y. Imamura et al., “Generation of pro-inflammatory and anti-inflammatory cytokines in the gut in zymosan-induced peritonitis,” Hiroshima Journal of Medical Sciences, vol. 49, no. 1, pp. 43–48, 2000. View at Google Scholar · View at Scopus
  38. D. Erdmann, A. C. Roth, J. Hussmann et al., “Skin allograft rejection and hyperbaric oxygen treatment in immune-histoincompatible mice,” Undersea & Hyperbaric Medicine, vol. 22, no. 4, pp. 395–399, 1995. View at Google Scholar · View at Scopus
  39. J. F. Hansbrough, J. G. Piacentine, and B. Eiseman, “Immunosuppression by hyperbaric oxygen,” Surgery, vol. 87, no. 6, pp. 662–667, 1980. View at Google Scholar · View at Scopus
  40. K. Saito, Y. Tanaka, T. Ota, S. Eto, and U. Yamashita, “Suppressive effect of hyperbaric oxygenation on immune responses of normal and autoimmune mice,” Clinical and Experimental Immunology, vol. 86, no. 2, pp. 322–327, 1991. View at Google Scholar · View at Scopus
  41. X. Xu, H. Yi, M. Kato et al., “Differential sensitivities to hyperbaric oxygen of lymphocyte subpopulations of normal and autoimmune mice,” Immunology Letters, vol. 59, no. 2, pp. 79–84, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. B. Kudchodkar, H. Jones, J. Simecka, and L. Dory, “Hyperbaric oxygen treatment attenuates the pro-inflammatory and immune responses in apolipoprotein E knockout mice,” Clinical Immunology, vol. 128, no. 3, pp. 435–441, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. L. J. Hall, E. Faivre, A. Quinlan, F. Shanahan, K. Nally, and S. Melgar, “Induction and activation of adaptive immune populations during acute and chronic phases of a murine model of experimental colitis,” Digestive Diseases and Sciences, vol. 56, no. 1, pp. 79–89, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Schippers, M. Muschaweck, T. Clahsen et al., “β7-Integrin exacerbates experimental DSS-induced colitis in mice by directing inflammatory monocytes into the colon,” Mucosal Immunology, vol. 9, pp. 527–538, 2016. View at Publisher · View at Google Scholar
  45. A. K. Lee, R. B. Hester, J. H. Coggin, and S. F. Gottlieb, “Increased oxygen tensions modulate the cellular composition of the adaptive immune system in BALB/c mice,” Cancer Biotherapy, vol. 8, no. 3, pp. 241–252, 1993. View at Publisher · View at Google Scholar · View at Scopus
  46. J. E. Qualls, A. M. Kaplan, N. Van Rooijen, and D. A. Cohen, “Suppression of experimental colitis by intestinal mononuclear phagocytes,” Journal of Leukocyte Biology, vol. 80, no. 4, pp. 802–815, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. G. Butler, J. C. Michaels, N. Al-Waili et al., “Therapeutic effect of hyperbaric oxygen in psoriasis vulgaris: two case reports and a review of the literature,” Journal of Medical Case Reports, vol. 3, article 7023, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. C.-C. Niu, S.-S. Lin, L.-J. Yuan et al., “Hyperbaric oxygen treatment suppresses MAPK signaling and mitochondrial apoptotic pathway in degenerated human intervertebral disc cells,” Journal of Orthopaedic Research, vol. 31, no. 2, pp. 204–209, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Weisz, A. Lavy, Y. Adir et al., “Modification of in vivo and in vitro TNF-α, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease,” Journal of Clinical Immunology, vol. 17, no. 2, pp. 154–159, 1997. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Schieber and N. S. Chandel, “ROS function in redox signaling and oxidative stress,” Current Biology, vol. 24, no. 10, pp. R453–R462, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Perše and A. Cerar, “Dextran sodium sulphate colitis mouse model: traps and tricks,” Journal of Biomedicine & Biotechnology, vol. 2012, Article ID 718617, 3 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Hultqvist, L. M. Olsson, K. A. Gelderman, and R. Holmdahl, “The protective role of ROS in autoimmune disease,” Trends in Immunology, vol. 30, no. 5, pp. 201–208, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. A. K. Pandurangan, N. Mohebali, M. E. Norhaizan, and C. Y. Looi, “Gallic acid attenuates dextran sulfate sodium-induced experimental colitis in BALB/c mice,” Drug Design, Development and Therapy, vol. 9, pp. 3923–3934, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. Yu, W. Tian, H. Zhang, and X. Chen, “Effects of hyperbaric oxygen and cyclosporin A on the levels of active oxygens and nitric oxide in spleens of skin transplanted mice,” Chinese Journal of Pathophysiology, vol. 16, pp. 1286–1288, 2000. View at Google Scholar
  55. L. Ma, P. Li, Z. Shi, T. Hou, X. Chen, and J. Du, “A prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer,” Ostomy/Wound Management, vol. 59, no. 3, pp. 18–24, 2013. View at Google Scholar · View at Scopus
  56. O. Altinel, S. Demirbas, E. Cakir et al., “Comparison of hyperbaric oxygen and medical ozone therapies in a rat model of experimental distal colitis,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 71, no. 3, pp. 185–192, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. A. L. Gill and C. N. A. Bell, “Hyperbaric oxygen: its uses, mechanisms of action and outcomes,” Monthly Journal of the Association of Physicians, vol. 97, no. 7, pp. 385–395, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. J. A. Forsythe, B.-H. Jiang, N. V. Iyer et al., “Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1,” Molecular and Cellular Biology, vol. 16, no. 9, pp. 4604–4613, 1996. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Flück, G. Breves, J. Fandrey, and S. Winning, “Hypoxia-inducible factor 1 in dendritic cells is crucial for the activation of protective regulatory T cells in murine colitis,” Mucosal Immunology, vol. 9, no. 2, pp. 379–390, 2016. View at Publisher · View at Google Scholar
  60. B. J. Saeedi, D. J. Kao, D. A. Kitzenberg et al., “HIF-dependent regulation of claudin-1 is central to intestinal epithelial tight junction integrity,” Molecular Biology of the Cell, vol. 26, no. 12, pp. 2252–2262, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Robinson, S. Keely, J. Karhausen, M. E. Gerich, G. T. Furuta, and S. P. Colgan, “Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition,” Gastroenterology, vol. 134, no. 1, pp. 145–155, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Karhausen, G. T. Furuta, J. E. Tomaszewski, R. S. Johnson, S. P. Colgan, and V. H. Haase, “Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis,” The Journal of Clinical Investigation, vol. 114, no. 8, pp. 1098–1106, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. C. J. Kelly, L. E. Glover, E. L. Campbell et al., “Fundamental role for HIF-1α in constitutive expression of human β defensin-1,” Mucosal Immunology, vol. 6, no. 6, pp. 1110–1118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. Y. Huang, W. Fang, Y. Wang, W. Yang, and B. Xiong, “Transforming growth factor-β1 induces glutathione peroxidase-1 and protects from H2O2-induced cell death in colon cancer cells via the Smad2/ERK1/2/HIF-1α pathway,” International Journal of Molecular Medicine, vol. 29, no. 5, pp. 906–912, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. E. R. Tuller, C. T. Beavers, J. R. Lou, M. A. Ihnat, D. M. Benbrook, and W.-Q. Ding, “Docosahexaenoic acid inhibits superoxide dismutase 1 gene transcription in human cancer cells: the involvement of peroxisome proliferator-activated receptor α and hypoxia-inducible factor-2α signaling,” Molecular Pharmacology, vol. 76, no. 3, pp. 588–595, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. N. Hatano, Y. Itoh, H. Suzuki et al., “Hypoxia-inducible factor-1α (HIF1α) switches on transient receptor potential ankyrin repeat 1 (TRPA1) gene expression via a hypoxia response element-like motif to modulate cytokine release,” The Journal of Biological Chemistry, vol. 287, no. 38, pp. 31962–31972, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. H.-J. Jeong, H.-S. Chung, B.-R. Lee et al., “Expression of proinflammatory cytokines via HIF-1α and NF-κβ activation on desferrioxamine-stimulated HMC-1 cells,” Biochemical and Biophysical Research Communications, vol. 306, no. 4, pp. 805–811, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. H.-J. Jeong, S.-H. Hong, R.-K. Park, T. Shin, N.-H. An, and H.-M. Kim, “Hypoxia-induced IL-6 production is associated with activation of MAP kinase, HIF-1, and NF-κB on HEI-OC1 cells,” Hearing Research, vol. 207, no. 1-2, pp. 59–67, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. M. A. Rahat, H. Bitterman, and N. Lahat, “Molecular mechanisms regulating macrophage response to hypoxia,” Frontiers in Immunology, vol. 2, article 45, 2011. View at Publisher · View at Google Scholar · View at Scopus